Research Triangle Park-based BioAesthetics Corp. has announced an additional clinical trial of its lead product candidate, a biologically derived allograft for patients needing nipple reconstruction.
Read More
Four North Carolina firms have raised nearly $10 million in new cash, according to SEC filings. Here are the details.
Read More
BioAesthetics, which provides a nipple-areolar complex graft for patients undergoing breast reconstruction, is stepping up plans to commercialize its lead product after having closed on $5 million in financing.
Read More
The Launch Place is joining investors backing BioAesthetics, which provides a nipple-areolar complex graft for patients undergoing breast reconstruction. Here are the details.
Read More
Thirty-seven investors contributed to the round, which kicked off on Sept. 9. The Triangle company is still seeking to raise another $1.7 million.
Read More
